[PDF][PDF] Remdesivir reduces mortality in immunocompromised patients hospitalized for COVID-19

E Mozaffari, A Chandak, RL Gottlieb, AC Kalil… - croiconference.org
Background♦ Remdesivir (RDV) reduced time to recovery and improved clinical outcomes
for COVID-19 patients in several randomized controlled trials1, 2; with additional evidence …

[引用][C] REMDESIVIR REDUCES MORTALITY IN IMMUNOCOMPROMISED PATIENTS HOSPITALIZED FOR COVID-19

E Mozaffari, A Chandak, RL Gottlieb, AC Kalil…